Elanco Animal Health Gross Profit 2016-2024 | ELAN

Elanco Animal Health annual/quarterly gross profit history and growth rate from 2016 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Elanco Animal Health gross profit for the quarter ending September 30, 2024 was $0.538B, a 7.4% decline year-over-year.
  • Elanco Animal Health gross profit for the twelve months ending September 30, 2024 was $2.436B, a 2.68% decline year-over-year.
  • Elanco Animal Health annual gross profit for 2023 was $2.486B, a 0.48% decline from 2022.
  • Elanco Animal Health annual gross profit for 2022 was $2.498B, a 5.09% decline from 2021.
  • Elanco Animal Health annual gross profit for 2021 was $2.632B, a 64.09% increase from 2020.
Elanco Animal Health Annual Gross Profit
(Millions of US $)
2023 $2,486
2022 $2,498
2021 $2,632
2020 $1,604
2019 $1,601
2018 $1,493
2017 $1,395
2016 $1,505
2015 $1,375
Elanco Animal Health Quarterly Gross Profit
(Millions of US $)
2024-09-30 $538
2024-06-30 $689
2024-03-31 $690
2023-12-31 $519
2023-09-30 $581
2023-06-30 $623
2023-03-31 $763
2022-12-31 $536
2022-09-30 $554
2022-06-30 $691
2022-03-31 $717
2021-12-31 $602
2021-09-30 $629
2021-06-30 $728
2021-03-31 $673
2020-12-31 $541
2020-09-30 $448
2020-06-30 $290
2020-03-31 $325
2019-12-31 $377
2019-09-30 $411
2019-06-30 $426
2019-03-31 $387
2018-12-31 $387
2018-09-30 $391
2018-06-30 $339
2018-03-31 $376
2017-12-31
2017-09-30 $321
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.580B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00